Header Logo

Connection

ERIC JONASCH to Early Termination of Clinical Trials

Back to Details
This is a "connection" page, showing publications ERIC JONASCH has written about Early Termination of Clinical Trials.
ERIC JONASCH
Connection Strength
0.034
Early Termination of Clinical Trials
  1. Everolimus Versus Sunitinib Prospective Evaluation in Metastatic Non-Clear Cell Renal Cell Carcinoma (ESPN): A Randomized Multicenter Phase 2 Trial. Eur Urol. 2016 05; 69(5):866-74.
    View in: PubMed
    Score: 0.034
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.